Welcome to our dedicated page for Bancorp SEC filings (Ticker: TBBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bancorp, Inc. (NASDAQ: TBBK) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a financial holding company. Through its subsidiary, The Bancorp Bank, N.A., the company focuses on fintech-oriented payments and lending, institutional banking, commercial and small business lending, real estate bridge lending and fleet management services. Its SEC filings explain how these activities affect its financial condition, capital position and risk profile.
On this page, you can review The Bancorp’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include discussions of net interest income, non-interest income from fintech fees, loan portfolio composition, capital ratios and funding sources. Current reports on Form 8-K provide timely disclosure of specific events, including earnings releases, senior note offerings, share repurchase authorizations, partnership expansions and executive appointments.
The Bancorp also uses registration statements, such as Form S-1, to describe offerings of senior notes and related terms, including maturity, interest payments and ranking of the securities. These documents outline how proceeds may be used, for example to refinance existing senior notes, support share repurchase programs or provide capital to its bank subsidiary.
In addition to these core filings, investors can track information related to The Bancorp’s capital structure, debt obligations and governance, as well as any insider transaction reports on Form 4 that may be filed by officers and directors. Stock Titan’s platform supplements these filings with AI-powered summaries that highlight key points, helping readers quickly understand complex disclosures in TBBK’s 10-K, 10-Q, 8-K and registration statements while retaining access to the full original documents.
Harris Ryan, EVP Head of Fintech Solutions at Bancorp, Inc. (TBBK), reported a sale of common stock. The filing shows an insider sale of 9,841 shares executed at prices ranging from $76.37 to $76.41. After the sale, the reporting person is shown as beneficially owning 129,598 shares directly and 2,483 shares indirectly through a 401(k) plan account. The transaction is coded as a standard sale transaction, and no derivative instruments are reported. The disclosure documents a routine reduction in the reporting person’s direct holdings while leaving a substantial residual stake and an indirect retirement-plan position.
The Bancorp Inc. (TBBK) Form 144 notice shows an insider sale of 9,841 common shares acquired as equity compensation on 02/09/2025. The shares are to be sold through Raymond James & Associates on 09/10/2025 on NASDAQ with an aggregate market value reported as $751,070.00. The filing reports 46,070,000 shares outstanding, and notes no securities sold by this person in the past three months. The filer certifies no undisclosed material adverse information and indicates cash payment for the acquisition.
Garry Gregor J, EVP and COO of Bancorp, Inc. (TBBK), reported sales of company common stock in early September 2025. The Form 4 discloses a sale of 468 shares on 09/05/2025 at $78 and a sale of 12,532 shares on 09/08/2025 at prices ranging from $75.13 to $75.30 (reported price $75.1398). After these transactions the filing shows 110,107 shares beneficially owned directly. The report also lists 4,456 shares held indirectly in a 401(k) plan account.
The document was signed by an attorney-in-fact, Martin Egan, on 09/08/2025. The form identifies the reporting person as EVP and COO and provides the issuer as Bancorp, Inc. (TBBK). The filing contains only the specified insider sales and the resulting share counts; no options or derivative transactions are reported.
The Bancorp Inc. (TBBK) filed a Form 144 proposing the sale of 13,000 shares of common stock through Raymond James & Associates on the NASDAQ on 09/05/2025. The filing lists an aggregate market value of $1,007,760 and reports 46,070,000 shares outstanding. The securities to be sold were acquired as equity compensation: 11,605 shares on 02/09/2025 (paid in cash) and 12,267 shares on 02/09/2024 (paid in cash). The filer states there were no securities sold in the past three months and affirms they do not possess undisclosed material information about the issuer.
The Bancorp, Inc. (TBBK) director Cheryl Creuzot reported a sale of company stock. On 08/22/2025 she sold 837 shares of common stock at a reported price of $71.87 per share and, following that transaction, beneficially owned 9,214 shares held directly. The Form 4 was signed by an attorney-in-fact on 08/25/2025 and was filed by one reporting person.
The Bancorp, Inc. (TBBK) filing a Form 144 reports a proposed sale of 900 shares of common stock held in a Pershing, LLC brokerage account on or about 08/22/2025. The filing states the aggregate market value of the shares is $60,777 and that 46,065,385 shares of the class are outstanding. The shares were acquired as restricted stock units (RSUs) granted by the issuer on 05/30/2024, with 2,784 RSU units reported as acquired on that date and paid via the RSU grant. No other securities sales in the past three months are reported. The filer certifies no undisclosed material adverse information.
The Bancorp, Inc. completed a $200,000,000 offering of 7.375% Senior Notes due 2030. The issuance was consummated under an underwriting agreement dated August 14, 2025, among the company, The Bancorp Bank, National Association, and Piper Sandler & Co. The filing references an existing indenture from August 13, 2020, a Second Supplemental Indenture dated August 18, 2025, and a form of the 7.375% Senior Note included with the supplemental indenture. The underwriting agreement contains customary representations, warranties, indemnification rights and termination provisions. The company disclosed the creation of a direct financial obligation in Item 2.03 and included a press release and Inline XBRL cover page as exhibits.
Insider sale reported by Bancorp, Inc. (TBBK): Jeffrey A. Nager, EVP and Head of Commercial Lending, reported selling common stock in multiple open-market transactions on 08/12/2025. The filings state the sales occurred at prices ranging from $66.69 to $66.8773.
The report shows 11,810 shares were disposed and that Mr. Nager's beneficial ownership following the reported transactions is 86,464 shares. No derivative transactions are listed in Table II. The filing provides transaction prices and the resulting share count but does not include explanation for the sales.
William H. Lamb, a director of The Bancorp, Inc. (TBBK), reported changes in his holdings via a Form 4 showing transfers coded as gifts. The reported transactions, dated 08/08/2025, transfer shares into four trusts whose beneficiaries include the reporting person’s grandchildren and a trust for his daughter; the form states the reporting person disclaims beneficial ownership of those trust-held shares.
The filing shows a direct beneficial holding of 218,235 shares following the reported transactions and 10,500 shares reported as indirectly owned (with two additional trust entries of 5,000 shares each listed). The transactions are recorded at $0, consistent with gifts rather than cash sales.
The Bancorp, Inc. (TBBK) filed a Form 144 reporting a proposed sale of 11,810 shares of common stock, with an aggregate market value of $767,650.00, through Capital Investment Brokerage on or about 08/13/2025 on Nasdaq. The filing states 46,065,385 shares outstanding, and the sale amount equals the total of two RSU grants listed.
The securities were acquired as compensation: 11,436 shares from an RSU grant dated 02/09/2024 and 374 shares from an RSU grant dated 02/17/2023. No sales by the person are reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.